M79.29
Conditions
Interventions
Group 1: Patients with Notalgia paraesthetica or brachioradial pruritus fill out several questionaires concerning clinical symptoms, quality of life and medical treatment regimens/costs and are treate
Sponsors
Astellas Pharma
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Diagnosis of notalgia paraesthetica or brachioradial pruritus with actual therapy need
Exclusion criteria
Exclusion criteria: Exclusion. 1. current and past (last 2 weeks) use of topical or systemic pain modulators (e.g., local anaesthetics in NP area, gabapentin, pregabalin), antidepressants (e.g., paroxetine, fluvoxamine, amitriptyline), antihistamines, topical or systemic steroids 2. diabetes, uncontrolled hypertension 3. history of skin disease or allergy likely to interfere with the study or known sensitivity to the test product or its ingredients, allergy to capsaicin 4. pregnancy, breast feeding 5. active psychosomatic and psychiatric diseases necessitating drug treatment 6. participation in any other research study during the previous 4 weeks. 7. previous participation in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacoeconomic and clinical evaluation of prescription patterns, symptoms, quality of life and nerve growth 3/6 months retrospectively and 3/6 months prospectively. | — |
Countries
Germany
Contacts
Public ContactSabine Stoll
Hautklinik UKM
Outcome results
None listed